How Effective Is Neoadjuvant Therapy Followed by Surgery for Pathologic Single-Station N2 Non-Small Cell Lung Cancer?

OBJECTIVE: The optimal treatment strategy for pathologic single-station N2 (pN2a1) non-small cell lung cancer (NSCLC)—surgery first followed by adjuvant treatment (SF) or neoadjuvant therapy followed by surgery (NS)—remains unclear. We compared disease-free survival (DFS) and overall survival (OS) a...

Full description

Saved in:
Bibliographic Details
Published in:Semin Thorac Cardiovasc Surg
Main Authors: Keshava, Hari B., Tan, Kay See, Dycoco, Joseph, Livschitz, Jennifer, Bott, Matthew J., Huang, James, Rusch, Valerie W., Isbell, James M., Molena, Daniela, Bains, Manjit S., Jones, David R., Rocco, Gaetano
Format: Artigo
Language:Inglês
Published: 2020
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7904958/
https://ncbi.nlm.nih.gov/pubmed/32853736
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.semtcvs.2020.08.006
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items